SOPHARMA (SPH) komunikat - Current report 32 buy back 07032013

POLISH FINANCIAL SUPERVISION AUTHORITY
		UNI - EN REPORT No		32	/	2013
Date of issue:	2013-03-07
Short name of the issuer
SOPHARMA AD
Subject
Current report 32 buy back 07032013
Official market - legal basis
Art. 56 ust. 1 pkt 1 Ustawy o ofercie - informacje poufne
Unofficial market - legal basis
Contents of the report:
The Board of Directors of SOPHARMA AD (the “Company") hereby informs that from 28 February 2013 up to and including 6 March 2013 the Company bought 7941 own shares representing 0.006% of the share capital of the Company, to the total value of BGN 17463.89 on the Bulgarian Stock Exchange. The average price per share was BGN 2.20. The shares have been bought on the basis of the general meeting resolution No. 7 of 23.06.2010. The total number of own shares after these transactions is 3621099, representing 2.74% of the share capital of the Company.
Annexes
File			Description
Current report 32 buy back 07032013.doc			Current report 32 buy back 07032013

SOPHARMA AD

(fullname of the issuer)

SOPHARMA AD

Farmaceutyczny (far)

(short name of the issuer)

(sector according to clasification
of the WSE in Warsow)

1220

Sofia

(post code)

(city)

IlienskoShosse

(street)

(number)

+359 2 813 42 00

+359 2 936 02 86

(phone number)

(fax)

(e-mail)

(web site)

(NIP)

(REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date	Name	Position / Function	Signature
2013-03-07	Ognian Donev	Executive director

Konta:	Konta osobiste Konta młodzieżowe Konta firmowe Konta walutowe
Kredyty:	Kredyty gotówkowe Kredyty mieszkaniowe Kredyty z dopłatą Kredyty dla firm

Current report 32 buy back 07032013